Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 3
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Dehdashti F, Wu N, Bose R, Naughton MJ, Ma CX, Marquez-Nostra BV, Diebolder P, Mpoy C, Rogers BE, Lapi SE, Laforest R, Siegel BA. Dehdashti F, et al. Among authors: marquez nostra bv. Breast Cancer Res Treat. 2018 Jun;169(3):523-530. doi: 10.1007/s10549-018-4696-z. Epub 2018 Feb 13. Breast Cancer Res Treat. 2018. PMID: 29442264 Free PMC article.
Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.
Massicano AVF, Lee S, Crenshaw BK, Aweda TA, El Sayed R, Super I, Bose R, Marquez-Nostra BV, Lapi SE. Massicano AVF, et al. Among authors: marquez nostra bv. Cancer Biother Radiopharm. 2019 May;34(4):209-217. doi: 10.1089/cbr.2018.2654. Epub 2019 Jan 24. Cancer Biother Radiopharm. 2019. PMID: 30676778 Free PMC article.
Targeting HER2 in Nuclear Medicine for Imaging and Therapy.
Massicano AVF, Marquez-Nostra BV, Lapi SE. Massicano AVF, et al. Among authors: marquez nostra bv. Mol Imaging. 2018 Jan-Dec;17:1536012117745386. doi: 10.1177/1536012117745386. Mol Imaging. 2018. PMID: 29357745 Free PMC article. Review.
Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with 89Zr in Human Lymphoma Xenografts.
Yoon JT, Longtine MS, Marquez-Nostra BV, Wahl RL. Yoon JT, et al. Among authors: marquez nostra bv. J Nucl Med. 2018 Aug;59(8):1219-1224. doi: 10.2967/jnumed.117.203299. Epub 2018 Jan 18. J Nucl Med. 2018. PMID: 29348316 Free PMC article.
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent.
Marquez-Nostra BV, Lee S, Laforest R, Vitale L, Nie X, Hyrc K, Keler T, Hawthorne T, Hoog J, Li S, Dehdashti F, Ma CX, Lapi SE. Marquez-Nostra BV, et al. Oncotarget. 2017 Nov 1;8(61):104303-104314. doi: 10.18632/oncotarget.22228. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262642 Free PMC article.
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.
Laforest R, Lapi SE, Oyama R, Bose R, Tabchy A, Marquez-Nostra BV, Burkemper J, Wright BD, Frye J, Frye S, Siegel BA, Dehdashti F. Laforest R, et al. Among authors: marquez nostra bv. Mol Imaging Biol. 2016 Dec;18(6):952-959. doi: 10.1007/s11307-016-0951-z. Mol Imaging Biol. 2016. PMID: 27146421 Free PMC article. Clinical Trial.
Feedback